AAIPharma Completes Acquisition of CAC and Launches New Business Unit
AAIPharma Completes CAC Acquisition
Wilmington, N.C., October 26, 2006--AAIPharma Inc. announced today that it has completed the previously announced acquisition of Cvitkovic & Associès Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting. CAC has clinical operations in France, Croatia, Russia, Spain, Argentina, Peru, Australia, and the United States. As a result of the acquisition, CAC has become the foundation of AAIOncology, a global business unit dedicated to oncology drug development.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
